We’re demonstrating the university’s commitment to public service through a well-run business.

— David Clark, Shield T3 CEO

> Shield T3

After COVID-19, a Future Supporting Health and Wellness with Advanced Testing

“It was an all-out sprint, quite frankly,” said Bill Jackson, DPI’s executive director, who serves as principal officer of Shield T3. “DPI and Shield T3 carry the university’s flag wherever it goes, and right now Shield T3 is serving more than 100 customers in 15 states.”

David Clark, CEO of Shield T3, added: “We’re proof that the University of Illinois System can put a business in place for social good and make it a success. We’re demonstrating the university’s commitment to public service through a well-run business.”

Shield T3 is working on a new test that will also catch influenza A and B, and respiratory syncytial virus, or RSV, a common and very contagious disease akin to a cold.

“We are going to test wastewater for opioids and many other pathogens that impact public health,” said Scott Cade, chief strat- egy officer for Shield T3. “With that and the broader saliva test, that also covers flu and RSV, we’re transforming into a health and wellness business.”